FDA current recommendations on using electronic health records - 2017

Fremont (United States), 8 May 2017


Key deadlines
Conference starts:
2017-05-08
Website

Visit the conference website

Conference Description

Overview:
This webinar will discuss FDA's current recommendations on using electronic health records in prospective clinical investigations of human drugs, biologics, medical devices and combination product.

Why should you Attend:
This training provides FDA's current recommendations on this topic. Check out the specific areas covered below. If you are a sponsor of a clinical trial involving a drug, biologic, medical device or combination product, a clinical investigator, a contract research organization (CRO) or an institutional review board (IRB), you stand to benefit from this training.

Areas Covered in the Session:
Whether and how to use EHRs as a source of data in clinical investigations
Using EHRs that are interoperable with electronic systems supporting clinical investigations

Who Will Benefit:
Institutional Review Boards (IRB)
Ethics Review Boards (ERB)
Research Ethics Boards (REB)

Speaker Profile:
Rachelle D'Souza , CEO of Regulatory Heights Inc., has successfully licensed various medical and consumer products and facilities with international regulatory authorities / agencies for multinational and start-up companies. Her expertise also includes clinical trial master file documentation, and the design and maintenance of globally compliant quality, safety / pharmacovigilance and medical information systems.

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com

Conference creator: compliance4all

Actions menu

Conference Location

image placeholder

161 Mission Falls Lane, Suite 216,,
Fremont 94539 (United States)

Tags for this conference

Comments

No comments yet!

You must register or sign in to post a comment.